APA (7th ed.) Citation

Zilberberg, M. D., Nathanson, B. H., Redell, M. A., Sulham, K., & Shorr, A. F. Comparative Outcomes of Meropenem–Vaborbactam vs. Ceftazidime–Avibactam Among Adults Hospitalized with an Infectious Syndrome in the US, 2019–2021. MDPI AG.

Chicago Style (17th ed.) Citation

Zilberberg, Marya D., Brian H. Nathanson, Mark A. Redell, Kate Sulham, and Andrew F. Shorr. Comparative Outcomes of Meropenem–Vaborbactam Vs. Ceftazidime–Avibactam Among Adults Hospitalized with an Infectious Syndrome in the US, 2019–2021. MDPI AG.

MLA (9th ed.) Citation

Zilberberg, Marya D., et al. Comparative Outcomes of Meropenem–Vaborbactam Vs. Ceftazidime–Avibactam Among Adults Hospitalized with an Infectious Syndrome in the US, 2019–2021. MDPI AG.